Welcome to the group!
We invite you to share your research, knowledge, and points of view here. This is a space to collaborate with fellow coaches to inspire and empower each other through discussion.
We ask that you please follow a few ground rules:
1: Never share, screenshot, or distribute any private or sensitive information posted by another member, inside or outside of the group.
2: Do not copy or reuse any specific coaching methods, frameworks, or content shared here without explicit, written permission from the owner.
3: Do not post links, recruit members, or solicit business for your own services, products, or webinars.
4: Please no hateful, discriminatory, abusive, or harassing language. Treat all members with professional respect.
Thank you and welcome!
This post is from a suggested group
For those of you who missed this inspiring event, please listen tot he recording here:
Passcode: Z3Z!FHjg
There were so many questions we simply did not have time to answer, so I am opening this discussion for everyone who is still reflecting on the event and have some questions to be able to ask them here.
This post is from a suggested group
The Phenylketonuria (PKU) Treatment Market is growing as genetic testing and early diagnosis improve outcomes for this rare metabolic disorder. PKU treatment involves strict dietary management, enzyme substitution therapy, and emerging gene therapy approaches.
Rising awareness about newborn screening programs and dietary interventions is driving Phenylketonuria Treatment Market trends. Pharmaceutical advancements, including enzyme replacement and chaperone therapies, are enhancing long-term patient compliance and metabolic control, reducing neurological complications associated with untreated PKU.
North America currently dominates due to established screening programs and access to specialized therapies, while Europe maintains steady growth. Asia-Pacific is emerging as a promising market with increasing awareness, government support, and improving access to therapies. The Phenylketonuria Treatment Market developments reflect ongoing research in gene editing and oral enzyme formulations, indicating potential for long-term sustainable treatment strategies.
FAQsQ1: What are the common treatments for PKU?A1: Diet management, enzyme therapy, and emerging gene therapies are commonly used.
Q2: Which factors…
This post is from a suggested group
Please use the following link for the upcoming events of EMCC USA: https://us06web.zoom.us/j/6440897647
This post is from a suggested group
Join us for the official launch of EMCC USA—a vibrant community for coaching, mentoring, supervision, and team coaching professionals. This special event will bring together thought leaders, accredited practitioners, and members from across the country to connect and celebrate the establishment of the EMCC USA as affiliation country on the map of EMCC Global.
Welcome & EMCC USA Board Introduction – Meet the leaders behind EMCC USA and hear their vision for our community.
Membership Opportunities – Discover the benefits of joining EMCC USA and how it can elevate your professional journey.
How you can get involved – Learn how you can contribute as a volunteer to different areas of needs now and in future as we scale and grow.
Networking & Q&A – Engage directly with us, share experiences, and explore ways to collaborate.
This post is from a suggested group
Join us for a dynamic and thought-provoking conversation with Prof. David Clutterbuck, Dr. Lise Lewis, Dr. Françoise Orlov, Sam Isaacson, and Karen Benoy Preston as they explore how coaching and supervision can evolve to meet the challenges—and opportunities—of a rapidly changing world.
Together, this powerhouse panel will honor the roots of our profession while co-creating a vision for what’s next. Through bold perspectives, live participant interaction, and AI-powered synthesis, they’ll examine how supervision can serve as the bridge between trusted human practice and an increasingly technology- and neurodiversity-aware future.
This is not a lecture—it’s a participatory dialogue designed to spark curiosity, reflection, contribution, and action. You’ll help shape the “Future Map of Coaching 2035,” identifying the next frontiers of practice while reaffirming what must remain timeless in our work.
A roadmap from roots to horizons: How coaching and supervision have evolved—and what that trajectory tells us about where we’re headed.
Staying human-centered in an AI and neurodivergence-informed world: Exploring how supervision anchors ethics, empathy,…
This post is from a suggested group
Welcome to our group Emcc Usa Group! A space for us to connect and share with each other. Start by posting your thoughts, sharing media, or creating a poll.
This was a great question from our chat "This weekend, I had a conversation with a Dubai-based coach. He stated that he works with C-Suite executives who are his "top athletes," which is why does not recognize coaching as defined by ICF or EMCC because that is not good enough for top executives. I wonder what we need to do to separate from the understanding of coaching in sports and continue legitimizing our deep work of mindset expansion, deepening, and stretch". What are your thoughts about how coaching athletes and sports teams differs from coaching leaders, businesses, individuals, relationships, or whatever else we might coach?